Medipostco메디포스트
078160 · KOSDAQ · ₩078160 · 메디포스트
₩8,090▼ ₩260 (3.11%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩74B | ₩71B | ₩69B | ₩64B | ₩55B |
| Cost of sales | ₩28B | ₩27B | ₩28B | ₩26B | ₩23B |
| Gross profit | ₩45B | ₩44B | ₩40B | ₩38B | ₩32B |
| Operating income | −₩68B | −₩49B | −₩25B | −₩17B | −₩5.2B |
| Net income | −₩86B | −₩63B | ₩5B | ₩2.1B | −₩966M |
| Net income to shareholders | −₩85B | −₩63B | ₩5.8B | ₩3.1B | −₩683M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩432B | ₩414B | ₩449B | ₩398B | ₩254B |
| Current assets | ₩128B | ₩135B | ₩194B | ₩152B | ₩81B |
| Cash and equivalents | ₩77B | ₩33B | ₩38B | ₩15B | ₩11B |
| Total liabilities | ₩182B | ₩162B | ₩136B | ₩215B | ₩92B |
| Current liabilities | ₩97B | ₩81B | ₩63B | ₩155B | ₩41B |
| Borrowings | ₩46B | ₩10B | ₩10B | ₩48B | ₩28B |
| Total equity | ₩250B | ₩253B | ₩314B | ₩183B | ₩162B |
| Shareholders' equity | ₩249B | ₩251B | ₩312B | ₩180B | ₩159B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩57B | −₩37B | −₩19B | −₩6.2B | ₩4.1B |
| Capital spending | ₩2.9B | ₩2.7B | ₩2.6B | ₩3.2B | ₩10B |
| Free cash flow | −₩60B | −₩40B | −₩22B | −₩9.4B | −₩6.1B |
Consolidated where available. Amounts in won.
Also known as: Medipostco / 메디포스트 / 078160 / KRX:078160
Source: KRX statistical information